Entrada Therapeutics
TRDA
#7493
Rank
NZ$0.53 B
Marketcap
$14.19
Share price
-1.00%
Change (1 day)
-38.17%
Change (1 year)

Entrada Therapeutics (TRDA) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.75 Billion

According to Entrada Therapeutics's latest financial reports the company has NZ$0.75 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Entrada Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.74 B33.81%
2023-12-31NZ$0.55 B87.25%
2022-12-31NZ$0.29 B-30.25%
2021-12-31NZ$0.42 B687.47%
2020-12-31NZ$54.11 M116.36%
2019-12-31NZ$25.01 M